BioCryst Pharmaceuticals Inc.

BCRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.81

+$0.05 (+0.57%)

Sep 22, 2026, 2:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	89.74M	104.92M	110.64M	304.77M	504.39M	272.13M
Short-Term Investments	185.01M	216.14M	278.34M	119.54M	3.21M	28.24M
Long-Term Investments	61.16M	21.72M	n/a	18.08M	6.83M	n/a
Other Long-Term Assets	29.66M	26.94M	80K	6.81M	n/a	3.8M
Receivables	106.82M	79.07M	56.95M	50.6M	29.41M	8.65M
Inventory	5.4M	8.09M	28.68M	27.53M	15.79M	7.04M
Other Current Assets	17.38M	13.75M	21.35M	14.06M	3.35M	2.22M
Total Current Assets	404.35M	421.97M	495.97M	516.5M	566.14M	323.8M
Property-Plant & Equipment	18.99M	19.79M	20.91M	8.62M	15.19M	7.11M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	109.81M	68.45M	20.99M	33.5M	22.02M	10.92M
Total Assets	514.16M	490.42M	516.96M	550M	588.15M	334.72M
Account Payables	15.83M	11.64M	20.89M	14.36M	27.81M	18.71M
Deferred Revenue	n/a	n/a	n/a	1.22M	1.42M	150K
Short-Term Debt	n/a	35.45M	n/a	n/a	n/a	30M
Other Current Liabilities	129.69M	64.66M	86.59M	36.46M	52M	44.58M
Total Current Liabilities	196.07M	160.38M	149.99M	105.51M	103.72M	105.65M
Long-Term Debt	427.23M	795.92M	811.27M	733.28M	585.46M	244.45M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	437.25M	805.97M	822.5M	739.08M	591.42M	248.32M
Total Liabilities	633.31M	966.35M	972.49M	844.6M	695.14M	353.98M
Total Debt	438.87M	841.42M	825.15M	741.45M	593.24M	279.5M
Book Value	-119.15M	-475.93M	-455.53M	-294.6M	-106.99M	-19.26M
Book Value Per Share	-0.55	-2.30	-2.37	-1.58	-0.60	-0.12
Common Stock	2.13M	2.09M	2.06M	1.88M	1.84M	1.77M
Retained Earnings	-1.51B	-1.77B	-1.68B	-1.45B	-1.21B	-1.02B
Comprehensive Income	38K	921K	1.34M	26K	177K	3K
Shareholders Equity	-119.15M	-475.93M	-455.53M	-294.6M	-106.99M	-19.26M
Total Investments	246.18M	237.86M	278.34M	137.62M	10.04M	28.24M